Viewing Study NCT07463651

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-06-22 @ 11:12 AM
Study NCT ID: NCT07463651
Status: RECRUITING
Last Update Posted: 2026-03-20
First Post: 2026-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Sponsor: The First Affiliated Hospital of Soochow University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia (AML) View
None FLT3-ITD Mutation View
None Allogeneic Hematopoietic Cell Transplantation (HCT) View
None Maintenance Therapy View
None Gilteritinib View
None Sorafenib View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute Myeloid Leukemia View
None FLT3-ITD Mutation View
None Allogeneic Hematopoietic Cell Transplantatio View
None Maintenance therapy View
None Gilteritinib View
None sorafeni View